Weiterstadt, Germany

Johanna Drögemüller

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biontech Se. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johanna Drögemüller. Retrieved from https://idiyas.com/inventor/johanna-drögemüller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Johanna Drögemüller: Innovator in In Vitro Transcription Technologies

Introduction

Johanna Drögemüller is a prominent inventor based in Weiterstadt, Germany. She has made significant contributions to the field of biotechnology, particularly in the area of in vitro transcription technologies. Her work focuses on the production of pharmaceutical-grade RNA, which is crucial for various medical applications.

Latest Patents

Johanna holds 1 patent related to in vitro transcription technologies. This patent provides innovative methods for conducting in vitro transcription reactions, especially aimed at large-scale production of high-quality RNA. Her advancements in this area are expected to have a substantial impact on the pharmaceutical industry.

Career Highlights

Johanna is currently employed at BioNTech SE, a leading biotechnology company known for its pioneering work in mRNA technology. Her role at BioNTech allows her to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Johanna has worked alongside talented colleagues, including Irena Rabe and Maximilian Buff. Their combined expertise fosters a collaborative environment that drives innovation and enhances the development of new technologies.

Conclusion

Johanna Drögemüller is a key figure in the advancement of in vitro transcription technologies, with her work at BioNTech SE paving the way for future innovations in RNA production. Her contributions are vital to the ongoing evolution of biotechnology and its applications in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…